Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Transplantation of human neural progenitor cells (NPCs) into the brain or spinal cord to replace lost cells, modulate the injury environment, or create a permissive milieu to protect and regenerate host neurons is a promising therapeutic strategy for neurological diseases. Deriving NPCs from human fetal tissue is feasible, although problematic issues include limited sources and ethical concerns. Here we describe a new and abundant source of NPCs derived from human induced pluripotent stem cells (iPSCs). A novel chopping technique was used to transform adherent iPSCs into free‐floating spheres that were easy to maintain and were expandable (EZ spheres) (Ebert et al. [2013] Stem Cell Res 10:417–427). These EZ spheres could be differentiated towards NPC spheres with a spinal cord phenotype using a combination of all‐trans retinoic acid (RA) and epidermal growth factor (EGF) and fibroblast growth factor‐2 (FGF‐2) mitogens. Suspension cultures of NPCs derived from human iPSCs or fetal tissue have similar characteristics, although they were not similar when grown as adherent cells. In addition, iPSC‐derived NPCs (iNPCs) survived grafting into the spinal cord of athymic nude rats with no signs of overgrowth and with a very similar profile to human fetal‐derived NPCs (fNPCs). These results suggest that human iNPCs behave like fNPCs and could thus be a valuable alternative for cellular regenerative therapies of neurological diseases. J. Comp. Neurol. 522:2707–2728, 2014. © 2014 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860 · cited 1×
“The melting curve was measured and recorded from 65 C to 95 C in increments of 0.05 C to 0.5 C. Genes of interest were normalized to housekeeping gene, RPL13A (ribosomal protein RL13A), and calculated by the 2-DDCT method (Schmittgen and Livak, 2008; Livak and Schmittgen, 2001)”
MethodInfluentialThe Glial Nature of Embryonic and Adult Neural Stem Cells
Kriegstein, A., & Alvarez-Buylla, A. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135600 · Cited by 2,475 · cited 1×
“Fetal neural progenitor cells (fNPCs) can be isolated from different regions of the developing human brain, expanded in culture, and then differentiated into neurons and glia (Kriegstein and Alvarez-Buylla, 2009; Conti and Cattaneo, 2010).”
BackgroundHuman induced pluripotent stem cells free of vector and transgene sequences
Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I. I., & Thomson, J. A. (2009) · Science · doi:10.1126/science.1172482 · Cited by 2,386
Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons
Nagai, M., Re, D. B., Nagata, T., Chalazonitis, A., Jessell, T. M., Wichterle, H., & Przedborski, S. (2007) · Nature Neuroscience · doi:10.1038/nn1876 · Cited by 1,220
Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis
Yamanaka, K., Chun, S. J., Boillee, S., Fujimori-Tonou, N., Yamashita, H., Gutmann, D. H., Takahashi, R., Misawa, H., & Cleveland, D. W. (2008) · Nature Neuroscience · doi:10.1038/nn2047 · Cited by 1,140 · cited 1×
“…been implicated in a number of neurodegenerative diseases, with perhaps the best example being ALS, where glial dysfunction has been shown to lead to non-cell autonomous death of the motor neurons (Nagai et al., 2007; Di Giorgio et al., 2007; Yamanaka et al., 2008; Haidet-Phillips et al., 2011).”
BackgroundThe changing scene of amyotrophic lateral sclerosis
Robberecht, W., & Philips, T. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3430 · Cited by 957 · cited 1×
“…cells (ESCs) derived from the blastocyst of a developing embryo, and induced PSCs (iPSCs) derived from reprogrammed adult somatic cells, have great potential for generating cells for use in regenerative and cell replacement strategies (Yamanaka, 2012; Robinton and Daley, 2012; Okano et al., 2013).”
BackgroundNon–cell autonomous effect of glia on motor neurons in an embryonic stem cell–based ALS model
Di Giorgio, F. P., Carrasco, M. A., Siao, M. C., Maniatis, T., & Eggan, K. (2007) · Nature Neuroscience · doi:10.1038/nn1885 · Cited by 799
Astrocytes from familial and sporadic ALS patients are toxic to motor neurons
Haidet-Phillips, A. M., Hester, M. E., Miranda, C. J., Meyer, K., Braun, L., Frakes, A., Song, S., Likhite, S., Murtha, M. J., Foust, K. D., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1957 · Cited by 782 · cited 1×
“…been implicated in a number of neurodegenerative diseases, with perhaps the best example being ALS, where glial dysfunction has been shown to lead to non-cell autonomous death of the motor neurons (Nagai et al., 2007; Di Giorgio et al., 2007; Yamanaka et al., 2008; Haidet-Phillips et al., 2011).”
BackgroundTargeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion
Sareen, D., O’Rourke, J. G., Meera, P., Muhammad, A. K. M. G., Grant, S., Simpkinson, M., Bell, S., Carmona, S., Ornelas, L., Sahabian, A., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007529 · Cited by 670 · cited 1×
“The melting curve was measured and recorded from 65 C to 95 C in increments of 0.05 C to 0.5 C. Genes of interest were normalized to housekeeping gene, RPL13A (ribosomal protein RL13A), and calculated by the 2-DDCT method (Schmittgen and Livak, 2008; Livak and Schmittgen, 2001)”
MethodInfluentialSelf-citationWindrem, M. S., Nunes, M. C., Rashbaum, W. K., Schwartz, T. H., Goodman, R. A., McKhann, G., Roy, N. S., & Goldman, S. A. (2004) · Nature Medicine · doi:10.1038/nm974 · Cited by 451 · cited 1×
“The anti-A2B5 monoclonal antibody (MAB312; Clone A2B5–105; Millipore) has been characterized by others to recognize A2B5-positive cells in fluorescence activated cell sorting (Windrem et al., 2004) and immunocytochemistry (Jiang et al., 2013).”
BackgroundLepore, A. C., Rauck, B., Dejea, C., Pardo, A. C., Rao, M. S., Rothstein, J. D., & Maragakis, N. J. (2008) · Nature Neuroscience · doi:10.1038/nn.2210 · Cited by 441
Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain
Andres, R. H., Horie, N., Slikker, W., Keren-Gill, H., Zhan, K., Sun, G., Manley, N. C., Pereira, M. P., Sheikh, L. A., McMillan, E. L., et al. (2011) · Brain · doi:10.1093/brain/awr094 · Cited by 329 · cited 1×
“We have previously shown that fNPCs transplanted into the brain, spinal cord, or retina in animal models of disease can survive and migrate, and provide beneficial effects in some cases (Wang et al., 2008; Andres et al., 2011; Nichols et al., 2013).”
BackgroundSelf-citationKobayashi, Y., Okada, Y., Itakura, G., Iwai, H., Nishimura, S., Yasuda, A., Nori, S., Hikishima, K., Konomi, T., Fujiyoshi, K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052787 · Cited by 315
Suppression of Hepatocyte Proliferation by Hepatocyte Nuclear Factor 4α in Adult Mice
Bonzo, J. A., Ferry, C. H., Matsubara, T., Kim, J.-H., & Gonzalez, F. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.334599 · Cited by 193
Zhou, J., Su, P., Li, D., Tsang, S., Duan, E., & Wang, F. (2010) · Stem Cells · doi:10.1002/stem.504 · Cited by 168
A call for standardized naming and reporting of human ESC and iPSC lines.
Luong, M. X., Auerbach, J., Crook, J. M., Daheron, L., Hei, D., Lomax, G., Loring, J. F., Ludwig, T., Schlaeger, T. M., Smith, K. P., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.03.002 · Cited by 56 · cited 1×
“Upon iPSC generation at Cedars Sinai, they were renamed 00iCTR-n2, 15iCTR-n5, and 83iCTR-n1 to reflect catalog number, control line, and clone number (Luong et al., 2011; Sareen et al., 2012).”
Method
Cited by
Multi-lineage human iPSC-derived platforms for disease modeling and drug discovery
Sharma, A., Sances, S., Workman, M. J., & Svendsen, C. N. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.02.011 · Cited by 296
“Human iPSC-derived neural tissues have been shown to integrate into rodent central nervous system tissues (Sareen et al., 2014) and in some cases have positive effects in models of neurodegenerative and eye diseases (Nori et al.”
BackgroundSelf-citationModeling ALS with motor neurons derived from human induced pluripotent stem cells
Sances, S., Bruijn, L. I., Chandran, S., Eggan, K., Ho, R., Klim, J. R., Livesey, M. R., Lowry, E., Macklis, J. D., Rushton, D., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4273 · Cited by 289
Self-citationCanfield, S. G., Stebbins, M. J., Morales, B. S., Asai, S. W., Vatine, G. D., Svendsen, C. N., Palecek, S. P., & Shusta, E. V. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13923 · Cited by 250
Self-citationComplex Tissue and Disease Modeling using hiPSCs
Passier, R., Orlova, V., & Mummery, C. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.02.011 · Cited by 142
“Derivation of mature astrocytes from hiPSCs has been reported (Roybon et al., 2013; Sareen et al., 2014).”
BackgroundScientific Validation of Human Neurosphere Assays for Developmental Neurotoxicity Evaluation
Koch, K., Bartmann, K., Hartmann, J., Kapr, J., Klose, J., Kuchovská, E., Pahl, M., Schlüppmann, K., Zühr, E., & Fritsche, E. (2022) · Frontiers in Toxicology · doi:10.3389/ftox.2022.816370 · Cited by 48
Metadata
- Authors
- Sareen, D., Gowing, G., Sahabian, A., Staggenborg, K., Paradis, R., Avalos, P., Latter, J., Ornelas, L., Garcia, L., & Svendsen, C. N.
- Venue
- Journal of Comparative Neurology
- Publisher
- Wiley
- Published
- 2014-04-12
- Volume
- 522
- Issue
- 12
- Pages
- 2707-2728
- ISSN
- 0021-9967 (ISSN-L)
- 1096-9861
- OpenAlex
- W1777924314
- Cited by
- 107
- References
- 16
- FWCI
- 5.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.